Nobel Prize in Physiology or Medicine 2026: Optogenetics and Light-Gated Ion Channels

This note covers the Nobel Prize in Physiology or Medicine 2026: who won it, how a light-sensitive algal protein called channelrhodopsin became a switch for nerve cells, how optogenetics developed step by step, why it matters for brain research and medicine, and quick facts for exams.

What was the Nobel Prize in Physiology or Medicine 2026 awarded for?

The official citation reads: "for their discoveries concerning light-gated ion channels and optogenetics". This is the exact wording used by the Nobel Assembly at Karolinska Institutet when announcing the award.

In plain words, two of the laureates, Peter Hegemann and Georg Nagel, found a protein in a tiny alga that opens a channel in a cell's outer covering when blue light shines on it.

The third laureate, Karl Deisseroth, then put this protein into nerve cells, so that shining light on those cells could switch them on in a precise, fast and controllable way. This technique for using light to control nerve cells is called optogenetics.

The award is officially called the Nobel Prize in Physiology or Medicine.

Before this discovery, scientists could watch brain activity but could not easily prove which exact nerve cells caused a particular feeling or action. The new tool let them switch specific nerve cells on or off and see the result immediately, turning guesswork into proof.

Who are the laureates?

Karl Deisseroth

Karl Deisseroth was born on 18 November 1971 in Boston, MA, USA. At the time of the award he was affiliated with the Howard Hughes Medical Institute and Stanford University in the USA, holding a share of one third of the prize.

He trained in both medicine and neuroscience, and his clinical work with psychiatric patients pushed him to look for better tools to study the brain.

He took the channelrhodopsin gene discovered by Hegemann and Nagel and introduced it into nerve cells, first rat nerve cells grown in a dish and then nerve cells in the brains of living mice, creating a practical light-controlled switch for neurons.

Peter Hegemann

Peter Hegemann was born on 11 December 1954 in Münster, Germany. At the time of the award he was at Humboldt University of Berlin, Germany, holding a share of one third of the prize.

His prize-winning discoveries were made earlier at the Max Planck Institute for Biochemistry in Martinsried.

Hegemann's curiosity about how the alga Chlamydomonas swims towards light led him to hypothesise, and later help prove, that a single protein in the alga both senses light and lets ions flow through it.

Georg Nagel

Georg Nagel was born on 24 August 1953 in Weingarten, Germany. At the time of the award he was a professor at the University of Würzburg, Germany, holding a share of one third of the prize.

His prize-winning work was done at the Max Planck Institute for Biophysics in Frankfurt. Nagel had the electrophysiology skills needed to insert the algal genes into frog egg cells and prove, by measuring electrical currents, that the protein was indeed a light-controlled ion channel.

What was the background problem?

Understanding how the brain creates memories, feelings and behaviour has puzzled researchers for centuries. The human brain weighs about 1.3 kilograms yet holds childhood memories, daydreams, joy, love and jealousy, and it also controls heartbeats, breathing and the sleep cycle.

The brain contains around 90 billion nerve cells, each forming thousands of connections, and cells controlling very different functions can sit right next to each other.

Through the twentieth century, researchers worked out which broad brain regions were linked to which functions, using methods such as electrical recording, brain lesions, drugs and imaging.

These methods could show a correlation between a brain area and a behaviour, but they could not show that one particular kind of nerve cell actually caused a feeling or an action. The Nobel Committee compares the picture of the brain they gave to a blurry photograph, missing many details.

The physicist and biologist Francis Crick, who had shared the 1962 Nobel Prize for the discovery of the DNA double helix, thought hard about this gap a few decades later, while investigating the mechanisms behind human consciousness.

He envisioned switching individual nerve cells on or off in a living brain. Because nerve signals happen in milliseconds, he reasoned that any such switch would ideally use light, since light can be turned on and off almost instantly. Crick admitted the idea sounded far-fetched, but perhaps not impossible.

The gap between Crick's idea and a working tool was filled by a completely different line of research: the study of how a swimming alga reacts to light. That curiosity-driven work, taken up by Peter Hegemann, eventually supplied exactly the switch neuroscience needed.

How does channelrhodopsin work as a light switch?

The alga Chlamydomonas is well known for swimming towards light: when researchers stir the green alga into a dish and shine light on one side, the green colour visibly drifts towards the light source.

The alga senses light using a tiny orange spot on its surface called the eyespot, which contains a light-capturing molecule called retinal.

Hegemann measured the electrical signals produced when the eyespot was lit, and found the reaction was extremely fast: an electrical impulse followed only about half a millisecond after the light hit the eyespot.

This was far quicker than the chain of chemical steps used in a human eye, which takes at least 10 milliseconds, making the algal response more than twenty times faster.

This speed convinced Hegemann, in the early 1990s, that a single protein must both capture light and act as an ion channel at the same time, rather than relying on a long chain of separate steps.

The idea met scepticism, because researchers at the time knew of many ion channels but none that reacted to light on their own.

Isolating the protein directly proved difficult, since it became unstable once removed from the alga. The breakthrough instead came from the Chlamydomonas genetic code: Hegemann's group found two candidate genes resembling known light-capturing proteins, and he then contacted Georg Nagel, who had the electrophysiology skills to test them.

Nagel injected copies of the two genes into frog egg cells, which began producing the unknown proteins on their outer membrane. He then measured the electrical currents and confirmed Hegemann's hypothesis: these proteins, named channelrhodopsin-1 and channelrhodopsin-2, were indeed ion channels that open when light falls on them.

1. Blue light strikes the channelrhodopsin protein sitting in the cell's outer membrane.
2. The light causes a shape change in the protein, opening a channel through it.
3. Positively charged ions flow into the cell through this open channel.
4. The inward flow of ions creates an electrical signal, called a depolarisation.
5. In a nerve cell, this signal can trigger a full nerve impulse that travels onward to other cells.

Hegemann and Nagel also tested introducing the channelrhodopsin-2 gene into human kidney cells and hamster kidney cells; both cell types became light-sensitive and produced an electrical signal when illuminated, showing the protein could work in almost any cell. They published this result in 2003.

Draw a cell membrane with a channelrhodopsin protein embedded in it. Show a blue light arrow hitting the protein, the channel opening, and small plus-signs (ions) flowing through into the cell, with an arrow pointing to a resulting electrical spike.

How did Deisseroth turn this into optogenetics?

Finding the protein in an alga was only half the task; it also had to work inside animal nerve cells.

In the 1990s, Karl Deisseroth trained in both medicine and neuroscience, and time spent with psychiatric patients made him want to understand why the brain works so differently from person to person, and what causes conditions such as depression, autism or schizophrenic delusions, especially as the treatments he could offer were rarely effective and often caused side effects.

When Deisseroth started his own laboratory, his team searched for a protein that could trigger electrical impulses in nerve cells on demand. Hearing about channelrhodopsin-2, he wrote to Georg Nagel to ask for the DNA encoding it.

He introduced this gene into rat nerve cells growing in a laboratory dish. The cells produced the protein without apparent harm, and when exposed to blue light they fired a nerve signal that passed on to other connected cells. He published this result in 2005.

Deisseroth then began collaborating widely, including with Hegemann and Nagel, and researchers, with Deisseroth's laboratory at the forefront, soon found further light-sensitive proteins that respond to different colours of light. In 2006, the overall method of using light to control genetically chosen nerve cells was named optogenetics.

One year later, Deisseroth's team made the method work inside the brain of a living mouse. They delivered the channelrhodopsin-2 gene into nerve cells in the motor cortex of a mouse's brain, the region that controls movement, then shone light into the brain through a very thin optical fibre inserted through a small hole in the skull. This let them trigger movement of the mouse's whiskers on command.

Also in 2007, together with other scientists, Deisseroth's group used light to wake sleeping mice on demand, by introducing channelrhodopsin-2 into a nerve cell type suspected of controlling wakefulness; shining light on these cells woke the mice, confirming the hypothesis.

In 2012, Deisseroth worked with Susumu Tonegawa, a 1987 Nobel laureate, to artificially activate the specific pattern of nerve cells, called an engram, that stored a fear memory in mice; reactivating these cells made the mice show fear even though they were not in danger.

Draw a mouse head in outline with a thin optical fibre entering through a small hole in the skull, reaching a group of nerve cells in the motor cortex that are shown lit up, with an arrow to a whisker moving.

How did the discovery unfold?

The path from a curious question about a single-celled alga, first asked in the early 1990s, to a working tool for neuroscience took about fifteen years.

The timeline below traces the major steps, from the first measurements of the channelrhodopsin protein in Chlamydomonas through to Karl Deisseroth's experiments in living mice.

Each step added a piece needed to turn Francis Crick's idea of a light-controlled nerve switch into working science.

Within less than ten years of the first channelrhodopsin papers, the resulting method, optogenetics, had moved from a single algal protein through cultured rat nerve cells and into the brains of living mice, and from there into laboratories worldwide studying memory, sleep and fear.

Why does optogenetics matter?

Optogenetics has let researchers identify which precise groups of nerve cells govern specific functions, such as the sense of pain, social behaviour, thirst, food intake, reward, attention, the body's internal clock, and fever responses linked to the immune system.

It has shown that even complicated behaviours, like the way mice look after their young, are controlled by separate neural circuits for separate parts of that behaviour; one circuit governs gathering the young into a nest, while another governs grooming them.

The method also connects the nervous system to other organs: Deisseroth's research has shown that heart rhythm can affect feelings of anxiety, and other researchers have identified gut cells linked to food preferences, such as why some people prefer sugar over sweeteners.

Per Svenningsson, Chair of the Nobel Committee for Physiology or Medicine, said: "Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of."

In medicine, optogenetics has deepened understanding of disorders such as Alzheimer's disease, Parkinson's disease, depression, anxiety and schizophrenia.

Clinical trials are underway that use the technique to try to restore some vision in people blinded by retinitis pigmentosa, an inherited disease in which the eye's rod and cone cells are gradually destroyed.

In one trial, researchers delivered a channelrhodopsin-like protein into the retina of a blind person, who then used special light-emitting glasses and regained the ability to discern and grasp high-contrast objects on a table.

Researchers also hope the approach could one day improve cochlear implants, which currently stimulate the hearing nerve using electricity, by instead activating the nerve with light for greater precision.

Open questions remain about how to safely deliver these light-sensitive genes and light sources inside the human body for routine treatment, beyond the research setting and the early clinical trials.

How does this connect to what you study?

This discovery links directly to school biology topics on the nervous system, nerve impulses and cell membranes.

A nerve cell is normally excited when ions cross its membrane through channels opened by chemical signals from neighbouring cells; channelrhodopsin is a different kind of ion channel, one that is opened directly by light instead of by a chemical signal.

It also connects to the basic biology idea that genes from one organism, here a single-celled alga, can be inserted into cells of a completely different organism, such as a rat or mouse, and still work correctly.

This is an example of using a gene from one species to change the behaviour of cells in another.

The discovery also illustrates how different branches of biology can come together unexpectedly: curiosity about how a tiny alga swims towards light, a question that seemed to have nothing to do with human medicine, supplied the exact switch that neuroscientists needed to study memory, emotion and disease.

Finally, the method shows how a protein's structure determines its function: because channelrhodopsin combines a light-sensor and an ion channel in one molecule, it reacts far faster than systems built from several separate proteins working in a chain, which links to the general biology idea that structure shapes speed and function.

What other tools has optogenetics added since its early days?

Driving nerve cells to fire was only half of what neuroscientists needed; they also wanted a way to switch chosen nerve cells off, to test what happens when a circuit is silenced rather than activated.

In 2007, two separate research teams, one working in Deisseroth's laboratory, adapted a different light-sensitive protein called halorhodopsin, taken from a salt-loving microbe. When lit with yellow light rather than blue, halorhodopsin pumps chloride ions into the cell, which silences the cell's firing rather than triggering it.

Because halorhodopsin responds to a different colour of light than channelrhodopsin, scientists could shine two different coloured lights on the same tissue and use the two colours of light in a single experiment to drive activity in a circuit and to silence it.

Later researchers found naturally occurring anion channels in another alga, Guillardia theta, in 2015, which silenced nerve cells more efficiently than the earlier pump-based proteins, further improving the efficiency of optogenetic silencing.

A related but separate approach called chemogenetics also emerged around 2007, using engineered receptors that respond only to a designer drug rather than to light.

This method works more slowly than optogenetics but its drug can be injected into the body and reaches the engineered receptors across large, widespread brain circuits, making it useful for longer-lasting changes in brain activity.

Together, these additional tools let researchers not just activate circuits but also silence them, compare colours of light for independent control, and choose between fast optical switches and slower drug-based switches depending on the experiment, giving neuroscience a much richer toolkit than channelrhodopsin alone.

Quick facts for exams

The Nobel Prize in Physiology or Medicine 2026 was announced on 5 October 2026 by the Nobel Assembly at Karolinska Institutet. It was awarded jointly, one third each, to Karl Deisseroth, Peter Hegemann and Georg Nagel for their work on light-gated ion channels and optogenetics.

Hegemann and Nagel discovered channelrhodopsin, a protein from the alga Chlamydomonas that opens an ion channel when struck by blue light.

Deisseroth then inserted this protein's gene into nerve cells, first in a dish in 2005 and then in a living mouse brain in 2007, creating a practical light-controlled switch for neurons.

This combined method is now called optogenetics, and it has let researchers map which exact nerve cells cause particular feelings, memories or behaviours, as well as inform early clinical trials for conditions such as vision loss.

The table below collects the exam-ready details: the prize year, the laureates with their countries of birth and affiliation at the time of the award, their shares, the official citation, the date of announcement and the prize amount.

Note: Source. The prize facts in this note are from the Nobel Prize's official site, nobelprize.org.

Glossary

• Optogenetics — a method of using light to switch specific, genetically chosen nerve cells on or off.
• Channelrhodopsin — a light-sensitive protein from algae that opens a channel for ions when hit by light.
• Ion channel — a protein in a cell membrane that lets charged particles (ions) pass through it.
• Eyespot — the light-sensing orange spot on the surface of the alga Chlamydomonas.
• Retinal — a light-capturing molecule found in channelrhodopsin and in the eyespot.
• Depolarisation — a fall in the voltage difference across a cell membrane, making the inside less negative, which can trigger a nerve signal.
• Motor cortex — the part of the brain that controls voluntary movement.
• Engram — the specific pattern of nerve cells that stores a particular memory.
• Retinitis pigmentosa — a disease that destroys the light-detecting rod and cone cells of the eye, causing blindness.
• Optical fibre — a very thin strand used to carry light into the brain to activate light-sensitive nerve cells.
• Phototaxis — the swimming movement of an organism, such as an alga, towards or away from light.
• Neural circuit — a connected group of nerve cells that together perform a particular function.

Common errors and misconceptions

• Misconception: Optogenetics means controlling the brain with genes alone. Correct: It needs both a light-sensitive gene inserted into cells and an actual light source shone on those cells.
• Misconception: Channelrhodopsin was discovered inside a nerve cell. Correct: It was first found and studied in the alga Chlamydomonas, then later put into nerve cells.
• Misconception: One laureate alone discovered the whole method. Correct: Hegemann and Nagel found the channelrhodopsin protein; Deisseroth then made it work as a nerve cell switch, including in living mice.
• Misconception: Optogenetics is already a routine human treatment. Correct: It is mainly a research tool, with clinical trials for conditions such as vision loss still ongoing.
• Misconception: The channel responds to any colour of light equally. Correct: Channelrhodopsin-2 is specifically activated by blue light.
• Misconception: The prize was for inventing a new drug. Correct: It was for discovering a light-controlled protein switch and the method of optogenetics, not a drug.

Exam-style questions with model answers

Q1. State the official citation for the Nobel Prize in Physiology or Medicine 2026. [2 marks]

1. "for their discoveries concerning light-gated ion channels and optogenetics", awarded jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel.

Q2. Name the three laureates and their affiliations at the time of the award. [2 marks]

1. Karl Deisseroth: Howard Hughes Medical Institute and Stanford University, USA. Peter Hegemann: Humboldt University of Berlin, Germany. Georg Nagel: University of Würzburg, Germany.

Q3. What is channelrhodopsin and where was it first found? [3 marks]

1. Channelrhodopsin is a light-sensitive protein that acts as an ion channel, opening when hit by blue light to let charged ions flow into a cell. It was first discovered in the single-celled alga Chlamydomonas, where it helps the alga sense light for swimming towards it.

Q4. Explain, in order, how channelrhodopsin creates an electrical signal in a cell. [4 marks]

1. Blue light strikes the channelrhodopsin protein in the cell membrane. The light causes the protein to change shape and open a channel. Positively charged ions then flow into the cell through this channel. This inward ion flow creates an electrical signal, called depolarisation, which in a nerve cell can trigger a full nerve impulse.

Q5. Describe how Karl Deisseroth turned channelrhodopsin into a tool for controlling nerve cells. [5 marks]

1. Deisseroth obtained the gene for channelrhodopsin-2 from Georg Nagel and inserted it into rat nerve cells growing in a dish. The cells produced the protein and, when exposed to blue light, fired a nerve signal, a result published in 2005. Two years later, his team delivered the gene into nerve cells of the motor cortex in a living mouse's brain and used a thin optical fibre inserted through the skull to shine light on those cells. This let them trigger movement of the mouse's whiskers on command, proving the method worked inside a living brain, not just in a dish. This technique came to be called optogenetics.

Q6. Discuss why optogenetics is considered important for neuroscience and medicine. [6 marks]

1. Before optogenetics, scientists could observe which brain regions were active during a behaviour, but could not prove that one particular type of nerve cell was the direct cause of that behaviour. Optogenetics solved this by letting researchers switch precisely chosen nerve cells on or off using light and watch the direct effect. This has allowed mapping of neural circuits for pain, social behaviour, thirst, feeding, reward, attention, body clock rhythms and fear memories. It has also revealed links between the nervous system and other organs, such as the heart and gut. In medicine, the method has deepened understanding of Alzheimer's disease, Parkinson's disease, depression, anxiety and schizophrenia, and clinical trials are testing it to restore partial vision in people with retinitis pigmentosa, with one patient regaining the ability to discern and grasp objects on a table using light-emitting glasses. Researchers also hope it may improve cochlear implants.

Q7. What problem in brain research existed before optogenetics, according to the Nobel Committee's account? [3 marks]

1. Earlier methods such as electrical recording, lesions, drugs and imaging could show correlations between brain areas and functions, but could not prove that one particular type of nerve cell was the direct cause of a given feeling or behaviour, leaving a blurry picture of the brain.

Q8. Give one clinical application of optogenetics mentioned in the sources. [2 marks]

1. Researchers used optogenetics in clinical trials to try to restore vision in a person blinded by retinitis pigmentosa, who regained the ability to distinguish and handle high-contrast objects using special light-emitting glasses.

Key takeaways

• Karl Deisseroth, Peter Hegemann and Georg Nagel share the 2026 Nobel Prize in Physiology or Medicine equally.
• The citation honours "discoveries concerning light-gated ion channels and optogenetics".
• Hegemann and Nagel discovered channelrhodopsin, a protein in algae that opens an ion channel when hit by blue light.
• Deisseroth's group published its use of the channelrhodopsin gene in rat nerve cells in 2005, then made it work in living mouse brains in 2007.
• The resulting method, named optogenetics in 2006, lets scientists switch specific nerve cells on or off using light.
• Optogenetics has mapped neural circuits for pain, memory, social behaviour, feeding and many other functions.
• Clinical trials now use the method in attempts to restore vision in people with retinitis pigmentosa.
• The discovery began with simple curiosity about how an alga swims towards light.

Test yourself

What does the word optogenetics combine?

It combines the use of light (optics) with genetically targeted control of specific nerve cells, so that light can switch chosen cells on or off.

Which alga was central to this discovery?

Chlamydomonas, a single-celled green alga known for swimming towards light, using a light-sensing eyespot on its surface.

What colour of light activates channelrhodopsin-2?

Blue light activates channelrhodopsin-2, opening its ion channel and letting positively charged ions flow into the cell.

In which year did Deisseroth's group first publish activating rat nerve cells with light?

2005, when they showed that rat nerve cells carrying the channelrhodopsin-2 gene fired a nerve signal when exposed to blue light.

What brain region did Deisseroth target to control mouse whisker movement?

The motor cortex, the brain area that governs movement, where he expressed channelrhodopsin-2 and illuminated it through a thin optical fibre.

Name one disease where optogenetics-based clinical trials are underway.

Retinitis pigmentosa, an inherited disease in which the eye's rod and cone cells are gradually lost; trials use light-sensitive proteins to try to restore some vision.

What memory-related structure did Deisseroth and Tonegawa activate in mice in 2012?

An engram, the specific pattern of nerve cells storing a particular fear memory, which they reactivated using optogenetics.